Tetrault LYNN A. is a director of Acelyrin Inc.
Person profile
Roles
Address
Fort Myers, Florida
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NEOGENOMICS INC
6 Mar 24
144
NEOGENOMICS INC
4 Mar 24
4
ACELYRIN, Inc.
20 Dec 23
3
ACELYRIN, Inc.
20 Dec 23
4
NEOGENOMICS INC
14 Aug 23
4
RHYTHM PHARMACEUTICALS, INC.
23 Jun 23
4
NEOGENOMICS INC
24 May 23
4
NEOGENOMICS INC
14 Jun 22
4
RHYTHM PHARMACEUTICALS, INC.
10 Jun 22
4
NEOGENOMICS INC
20 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 23 | SLRN Acelyrin | Director Stock Option Common Stock | Grant | Acquire A | No | No | 7.29 | 89,955 | 655.77 k | 89,955 |
10 Aug 23 | NEO Neogenomics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 11,336 | 0.00 | 11,336 |
10 Aug 23 | NEO Neogenomics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.82 | 8,353 | 123.79 k | 8,353 |
21 Jun 23 | RYTM Rhythm Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 3,000 | 0.00 | 3,000 |
21 Jun 23 | RYTM Rhythm Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 18.47 | 14,000 | 258.58 k | 14,000 |
22 May 23 | NEO Neogenomics | Common Stock | Option exercise | Acquire M | No | No | 11.6 | 1,507 | 17.48 k | 56,174 |
22 May 23 | NEO Neogenomics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 11.6 | 1,507 | 17.48 k | 0 |